ADMA Biologics, Inc. (ADMA)
11.01
+0.27
(+2.51%)
USD |
NASDAQ |
Apr 17, 16:00
11.06
+0.05
(+0.45%)
After-Hours: 20:00
ADMA Biologics SG&A Expense (Quarterly) : 24.64M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| Inovio Pharmaceuticals, Inc. | 7.215M |
| ANI Pharmaceuticals, Inc. | 82.79M |
| Eli Lilly & Co. | 3.132B |
| Ligand Pharmaceuticals, Inc. | 25.03M |